Open access
Sep 2026
Efficacy and safety of risk-adapted modified stereotactic body radiotherapy for lung tumors: a single-institution retrospective study.
Risk-adapted SBRT with increased fractionation demonstrated encouraging LC while maintaining an acceptable toxicity profile for central and ultracentral lung tumors, however, the risk of severe toxicity remains, requiring careful patient selection and optimized OAR dose constraints.
Akiko Oka, Hideomi Yamashita, Y. Miki et al.
· Journal of Radiation Researc... · 0 citations